United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2019_register
executive
2019-08-01
article
Prescription Drug User Fee Rates for Fiscal Year 2020
Notices
D09002ee1bdb6f1ff
D09002ee1bdb6f290
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing the rates for prescription drug user fees for fiscal year (FY) 2020. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2017 (PDUFA VI), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products, and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2020.
84 FR 37882
https://www.govinfo.gov/app/details/FR-2019-08-02/2019-16435
2019-16435
fr02au19-83
4164-01-P
Docket No. FDA-2017-N-0007
https://www.govinfo.gov/app/details/FR-2019-08-02/2019-16435
https://www.govinfo.gov/content/pkg/FR-2019-08-02/html/2019-16435.htm
https://www.govinfo.gov/content/pkg/FR-2019-08-02/pdf/2019-16435.pdf
5 p.
37882
37886
84 FR 37882
Prescription Drug User Fee Rates for Fiscal Year 2020; Federal Register Vol. 84, Issue
NOTICE
2019-16435
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2017-N-0007
4164-01-P
2019-16435
Notice.
The Food and Drug Administration (FDA) is announcing the rates for prescription drug user fees for fiscal year (FY) 2020. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2017 (PDUFA VI), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products, and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2020.
Melissa Hurley, Office of Financial Management, Food and Drug Administration, 4041 Powder Mill Rd., Rm. 61075, Beltsville, MD 20705-4304, 240-402-4585.
Prescription Drug User Fee Rates for Fiscal Year 2020
,
https://data.bls.gov/pdq/SurveyOutputServlet?data_tool=dropmap&series_id=CUURS35ASA0,CUUSS35ASA0
https://userfees.fda.gov/pay
https://www.bls.gov/cpi/additional-resources/geographic-revision-2018.htm
https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm511438.pdf
Pay.gov
Federal Register
Vol. 84, no. 149
Office of the Federal Register, National Archives and Records Administration
2019-08-02
continuing
daily
deposited
born digital
213 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2019-08-02
P0b002ee1a2580ce6
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr02au19
https://www.govinfo.gov/app/details/FR-2019-08-02
https://www.govinfo.gov/content/pkg/FR-2019-08-02/pdf/FR-2019-08-02.pdf
https://www.govinfo.gov/content/pkg/FR-2019-08-02/xml/FR-2019-08-02.xml
fdlp
37751
37954
DGPO
2019-08-01
2023-04-28
FR-2019-08-02
machine generated
eng
FR
FR-2019-08-02
84
149